Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Science and Technology Investment Group is a state-owned investment platform based in Chengdu, China, focusing on fostering innovation in high-tech sectors, particularly life sciences and biotechnology. The group manages various government-guided funds and direct investments aimed at developing the Chengdu Hi-Tech Zone and the Chengdu Tianfu International Bio-town. It provides financial support, industrial incubation, and infrastructure services to startups and established firms in the pharmaceutical, medical device, and healthcare services industries. By partnering with academic institutions and global enterprises, the company plays a pivotal role in establishing Chengdu as a major hub for the global bio-economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Sci-Tech Investment.